Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ABILIFY
- Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)
- Aripiprazole in Body Focused Repetitive Behaviors
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
- Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
- Propranolol for Challenging Behaviors in Autism
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
- A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
- A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
- CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
- MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
- Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
- Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
- Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
- Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
- Combination Treatment for Augmenting Language in Children With ASD
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
- Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia
- Fluoxetine vs Aripiprazole Comparative Trial (FACT)
- Pan European Collaboration on Antipsychotic Naïve Schizophrenia II
- Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
- Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- European Long-acting Antipsychotics in Schizophrenia Trial
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
- A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
- Antipsychotic Effects on Brain Function in Schizophrenia
- Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
- Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
- Canadian Biomarker Integration Network for Depression Study
- An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
- Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
- Bergen Psychosis Project 2 - The Best Intro Study
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
- Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
- Aripiprazole Effects on Alcohol Drinking and Craving
- Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder
- Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
- FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
- Oral Aripiprazole Open-Label Rollover Study
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
- Trial of Aripiprazole in Trichotillomania
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
- Aripiprazole and Topiramate on Free-Choice Alcohol Use
- Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
- Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
- Oral Uridine for Treatment of Bipolar Depression in Adolescents
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
- Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
- Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
- Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects
- Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
- A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
- Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
- Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
- Study of Aripiprazole to Treat Children and Adolescents With Autism
- Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression
- Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
- Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
- The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
- Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
- Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents
- Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
- Early Detection and Intervention for the Prevention of Psychosis
- Health Evaluation of Abilify Long-term Therapy
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
- ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
- Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children
- Metabolic Signatures and Biomarkers in Schizophrenia
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
- Bioequivalence Study of Atazanavir 300 mg Capsule
- Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
- Aripiprazole and Effexor XR Drug Interaction Study
- Aripiprazole and Lexapro Drug Interaction Study
- The New Strategy for Pharmacological Treatment in People With Schizophrenia
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Effect on Cognitive Function of a Treatment With Aripiprazole
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
- Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
- An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
- SWitching to Abilify Trial (SWAT)
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
- Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
- Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
- Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
- A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
- Aripiprazole Augmentation Therapy in Treatment-resistant Depression
- Aripiprazole to Reduce Cocaine Relapse
- A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
- Trial of Aripiprazole in the Treatment of CD in Adolescents
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
- Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
- Schizophrenia Trial of Aripiprazole
- A Switch Study of BMS-337039 in Schizophrenic Out-patients
- Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)
- An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder
- Abilify as an Adjunctive Treatment for Refractory Depression
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)
- Aripiprazole in Children With Autism: A Pilot Study
- Abilify Therapy for Reducing Comorbid Substance Abuse
- Metabolic Effects of Antipsychotics in Children
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
- A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
- Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
- Aripiprazole in Late Life Bipolar Disorder
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder
- Aripiprazole as Augmentation for TRD
- A Study of Aripiprazole in Patients With Major Depressive Disorder
- Aripiprazole Oral Acceptability Trial
- Study of Aripiprazole in Patients With Acute Bipolar Mania
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
- Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
- A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
- Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
- Study of Aripiprazole in Subjects With Alcoholism
- Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
- Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
- Switching Medication to Treat Schizophrenia
Clinical trials list
click for details